RAB34 was a progression- and prognosis-associated biomarker in gliomas.
about
Upregulated long intergenic noncoding RNA KRT18P55 acts as a novel biomarker for the progression of intestinal-type gastric cancer.Immunohistochemical Markers Distinguishing Cholangiocellular Carcinoma (CCC) from Pancreatic Ductal Adenocarcinoma (PDAC) Discovered by Proteomic Analysis of Microdissected CellsDetection of selection signatures of population-specific genomic regions selected during domestication process in Jinhua pigs.Consequences of Rab GTPase dysfunction in genetic or acquired human diseases.
P2860
RAB34 was a progression- and prognosis-associated biomarker in gliomas.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
RAB34 was a progression- and prognosis-associated biomarker in gliomas.
@en
type
label
RAB34 was a progression- and prognosis-associated biomarker in gliomas.
@en
prefLabel
RAB34 was a progression- and prognosis-associated biomarker in gliomas.
@en
P2093
P2860
P1433
P1476
RAB34 was a progression- and prognosis-associated biomarker in gliomas.
@en
P2093
Chuan-lu Jiang
Hong-jun Wang
Yong-li Li
P2860
P2888
P304
P356
10.1007/S13277-014-2732-0
P577
2014-12-13T00:00:00Z
P6179
1025375108